Abstract
Clinical Pharmacology & TherapeuticsVolume 77, Issue 3 p. 226-228 Letter to the Editor Modulation of Celecoxib Pharmacokinetics by Food in Pediatric Patients Diana Stempak MSc, Diana Stempak MSc New Agents and Innovative Therapy Program, Divisions of Hematology/Oncology and Clinical Pharmacology and Toxicology, Hospital for Sick Children, Toronto, Ontario, CanadaSearch for more papers by this authorJanet Gammon BScN, RN, Janet Gammon BScN, RN New Agents and Innovative Therapy Program, Division of Hematology/Oncology, Hospital for Sick Children, Toronto, Ontario, CanadaSearch for more papers by this authorJacqueline Halton MD, Jacqueline Halton MD Children's Hospital of Eastern Ontario, Ottawa, Ontario, CanadaSearch for more papers by this authorMartin Champagne MD, Martin Champagne MD Hôpital Sainte-Justine, Montreal, Quebec, CanadaSearch for more papers by this authorGideon Koren MD, Gideon Koren MD Division of Clinical Pharmacology and Toxicology, Hospital for Sick Children, Toronto, Ontario, CanadaSearch for more papers by this authorSylvain Baruchel MD, Corresponding Author Sylvain Baruchel MD [email protected] New Agents and Innovative Therapy Program, Division of Hematology/Oncology, Hospital for Sick Children, Toronto, Ontario, CanadaSearch for more papers by this author Diana Stempak MSc, Diana Stempak MSc New Agents and Innovative Therapy Program, Divisions of Hematology/Oncology and Clinical Pharmacology and Toxicology, Hospital for Sick Children, Toronto, Ontario, CanadaSearch for more papers by this authorJanet Gammon BScN, RN, Janet Gammon BScN, RN New Agents and Innovative Therapy Program, Division of Hematology/Oncology, Hospital for Sick Children, Toronto, Ontario, CanadaSearch for more papers by this authorJacqueline Halton MD, Jacqueline Halton MD Children's Hospital of Eastern Ontario, Ottawa, Ontario, CanadaSearch for more papers by this authorMartin Champagne MD, Martin Champagne MD Hôpital Sainte-Justine, Montreal, Quebec, CanadaSearch for more papers by this authorGideon Koren MD, Gideon Koren MD Division of Clinical Pharmacology and Toxicology, Hospital for Sick Children, Toronto, Ontario, CanadaSearch for more papers by this authorSylvain Baruchel MD, Corresponding Author Sylvain Baruchel MD [email protected] New Agents and Innovative Therapy Program, Division of Hematology/Oncology, Hospital for Sick Children, Toronto, Ontario, CanadaSearch for more papers by this author First published: 07 March 2005 https://doi.org/10.1016/j.clpt.2004.10.015Citations: 3Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Citing Literature Volume77, Issue3March 2005Pages 226-228 RelatedInformation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
